[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @AnotherBio AnotherBioInvestor AnotherBioInvestor posts on X about $bpmc, faster, $ckpt, $vigl the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::1364531118830219266/interactions)  - X Week XXXXXX +330% - X Month XXXXXX +51% - X Months XXXXXXX +5,978% - X Year XXXXXXX +520% ### Mentions: X [#](/creator/twitter::1364531118830219266/posts_active)  - X Week XX +85% - X Month XX +54% - X Months XXX +2,475% - X Year XXX +215% ### Followers: XXXXX [#](/creator/twitter::1364531118830219266/followers)  - X Week XXXXX +6.40% - X Month XXXXX +19% - X Months XXXXX +111% - X Year XXXXX +128% ### CreatorRank: XXXXXXX [#](/creator/twitter::1364531118830219266/influencer_rank)  ### Social Influence [#](/creator/twitter::1364531118830219266/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% [finance](/list/finance) XXXX% [countries](/list/countries) XXXX% **Social topic influence** [$bpmc](/topic/$bpmc) 7.14%, [faster](/topic/faster) 2.38%, [$ckpt](/topic/$ckpt) 2.38%, [$vigl](/topic/$vigl) 2.38%, [sanofi](/topic/sanofi) 2.38%, [tang](/topic/tang) 2.38%, [decent](/topic/decent) 2.38%, [$itos](/topic/$itos) 2.38%, [$srpt](/topic/$srpt) 2.38%, [$sny](/topic/$sny) XXXX% **Top accounts mentioned or mentioned by** [@ljp0101](/creator/undefined) [@adar170](/creator/undefined) [@biohazard3737](/creator/undefined) [@forever_dna](/creator/undefined) [@joinyellowbrick](/creator/undefined) [@richtrades100](/creator/undefined) [@bluejaunt100](/creator/undefined) [@investspecial](/creator/undefined) [@107_taste](/creator/undefined) [@somecuriousgirl](/creator/undefined) [@100xcompounding](/creator/undefined) [@dt432123](/creator/undefined) [@gbylenok](/creator/undefined) [@simplicitasopes](/creator/undefined) [@roccolefkowitz2](/creator/undefined) [@leveredvalue](/creator/undefined) **Top assets mentioned** [Blueprint Medicines Corporation (BPMC)](/topic/$bpmc) [Sanofi (SNY)](/topic/sanofi) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Synthetify (SNY)](/topic/$sny) [Illumina, Inc. (ILMN)](/topic/$ilmn) [Bitcoin Incognito (XBI)](/topic/$xbi) [Biogen Inc (BIIB)](/topic/$biib) [Sage Therapeutics, Inc (SAGE)](/topic/$sage) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) ### Top Social Posts [#](/creator/twitter::1364531118830219266/posts) --- Top posts by engagements in the last XX hours "$VIGL moving very quickly. Estimated closing time was based on CKPT (+10 days to be conservative). $VIGL filed first prem14a today HSR already filed as well will expire July XX midnight. First prem14a+HSR took Sanofi XX days $CKPT needed XX for first filing and XX for HSR filing. Guess its sensible to assume this closes faster than initially expected. Probably yielding around XX% annualized if closing in early August AND you get the CVR for free. Should rerate quite a bit but what do I know"  [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1934712150670311760) 2025-06-16 20:38:16 UTC 1121 followers, 4823 engagements "$ITOS came in very weak unfortunately did not expect ITOS to pay XX mln to GSK but well here we are. Some buys under water but decent win all around. Also - again - hate the "If Kevin Tang does nothing for X months he gets all assets"-CVR-structure. Why Just why Sold a large portion of shares today but still hold a respectable position. Unfortunately this is just a black box since net cash schedule is not disclosed. At XX cents ($ITOS XXXXX if you account for timevalue its XX cents) the CVR sits at 4.3mln ish. For a net cash sweep and these assets Why not. Cant say Im excited about this but"  [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1947372430160498914) 2025-07-21 19:05:42 UTC 1137 followers, 1186 engagements "$SRPT So they will probably do 1-2 bln in profits a year after everyone forgets about this and the stock sits at. 2.8bln $ Okay. (I know its more complicated than that but also.not really)"  [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945577991792124366) 2025-07-16 20:15:14 UTC 1135 followers, 7754 engagements "$BPMC might be last trading day today info from nasdaqtrader has not been accurate always (though no idea what the source for errors in the past was might not be them)"  [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945439044365615342) 2025-07-16 11:03:07 UTC 1136 followers, 1370 engagements "$BPMC lol I think thats a new one for me. You can unvalidly tender nice"  [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945733871095468272) 2025-07-17 06:34:39 UTC 1136 followers, 3010 engagements "$ILMN acquires SomaLogic from $LAB implied sales multiple probably around the 3X ballpark given deferred payment / royalties. Should reflect positively on $SEER - similar transaction would value it at 4.40$+ per share"  [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1937130967405080970) 2025-06-23 12:49:47 UTC 1125 followers, 1567 engagements "Hate to be a panican and am far from deep in the woods on $REPL but I think this will weigh heavily on $XBI $BBC in the short term. Not because of the CRL per se but because of this: "The CRL also states that there are items related to the confirmatory trial study design which need to be addressed including contribution of component" This means you can basically not rely on any pre-MAHA-communication and will kill confidence from companies as well as investors. $REPL 10$ Puts changing hands for 1$ yesterday clearly show that this was not expected (especially the "oh and btw screw your"  [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1947634422846460161) 2025-07-22 12:26:46 UTC 1136 followers, 2564 engagements "$PRTC Made a post already yday on strong words of CEO / Chair in annual letter but have to follow up on this after reading the transcript. This is the most shareholder-friendly language I have seen in a long time in biotech (if not ever this is biotech though so bar is low 🙃) and coming from a highly credible company - one that already actually did a buyback and tender offer. The fact that you can buy this basically unchanged from this conference call is somewhat mindblowing to me"  [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1917850434221363269) 2025-05-01 07:55:50 UTC 1137 followers, 4021 engagements "There was some interest on $BPMC thought Id write down. Didnt do a "KIT inhibitor" deep dive though scientific input welcome. link in bio / comment"  [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1943671058348880066) 2025-07-11 13:57:46 UTC 1136 followers, 2475 engagements "$SAGE might have a weak day. $BIIB announced its intent to tender its shares. Some folks were hoping for a last-minute-counteroffer from BIIB (they own XX% of Zuruvae) which should be completely off the table now"  [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1947639324503130416) 2025-07-22 12:46:15 UTC 1136 followers, 1240 engagements "$BBIO Never talked much about this on here have sold the majority of my shares over the last couple of days. Rationale: X. At XXXX bn$ EV its a different beast than in 20s obviously X. We are all expecting strong Q2 numbers anyway X. If numbers are good KKR dumps again X. If numbers or outlook somehow disappoint (dont think so but what do I know) will be punished severely X. We are around the conversion price for over XXX bln$ of convertibles delta-hedging will put incremental pressure on the stock Just think that this combination is a tough setup into Q2 numbers but maybe Im extrapolating"  [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1946201583898771816) 2025-07-18 13:33:10 UTC 1137 followers, 1342 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@AnotherBio AnotherBioInvestor
AnotherBioInvestor posts on X about $bpmc, faster, $ckpt, $vigl the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXXX +330%
- X Month XXXXXX +51%
- X Months XXXXXXX +5,978%
- X Year XXXXXXX +520%
Mentions: X #
- X Week XX +85%
- X Month XX +54%
- X Months XXX +2,475%
- X Year XXX +215%
Followers: XXXXX #
- X Week XXXXX +6.40%
- X Month XXXXX +19%
- X Months XXXXX +111%
- X Year XXXXX +128%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks XXXX% finance XXXX% countries XXXX%
Social topic influence $bpmc 7.14%, faster 2.38%, $ckpt 2.38%, $vigl 2.38%, sanofi 2.38%, tang 2.38%, decent 2.38%, $itos 2.38%, $srpt 2.38%, $sny XXXX%
Top accounts mentioned or mentioned by @ljp0101 @adar170 @biohazard3737 @forever_dna @joinyellowbrick @richtrades100 @bluejaunt100 @investspecial @107_taste @somecuriousgirl @100xcompounding @dt432123 @gbylenok @simplicitasopes @roccolefkowitz2 @leveredvalue
Top assets mentioned Blueprint Medicines Corporation (BPMC) Sanofi (SNY) Sarepta Therapeutics, Inc. (SRPT) Synthetify (SNY) Illumina, Inc. (ILMN) Bitcoin Incognito (XBI) Biogen Inc (BIIB) Sage Therapeutics, Inc (SAGE) BridgeBio Pharma, Inc. Common Stock (BBIO)
Top Social Posts #
Top posts by engagements in the last XX hours
"$VIGL moving very quickly. Estimated closing time was based on CKPT (+10 days to be conservative). $VIGL filed first prem14a today HSR already filed as well will expire July XX midnight. First prem14a+HSR took Sanofi XX days $CKPT needed XX for first filing and XX for HSR filing. Guess its sensible to assume this closes faster than initially expected. Probably yielding around XX% annualized if closing in early August AND you get the CVR for free. Should rerate quite a bit but what do I know"
@AnotherBio on X 2025-06-16 20:38:16 UTC 1121 followers, 4823 engagements
"$ITOS came in very weak unfortunately did not expect ITOS to pay XX mln to GSK but well here we are. Some buys under water but decent win all around. Also - again - hate the "If Kevin Tang does nothing for X months he gets all assets"-CVR-structure. Why Just why Sold a large portion of shares today but still hold a respectable position. Unfortunately this is just a black box since net cash schedule is not disclosed. At XX cents ($ITOS XXXXX if you account for timevalue its XX cents) the CVR sits at 4.3mln ish. For a net cash sweep and these assets Why not. Cant say Im excited about this but" @AnotherBio on X 2025-07-21 19:05:42 UTC 1137 followers, 1186 engagements
"$SRPT So they will probably do 1-2 bln in profits a year after everyone forgets about this and the stock sits at. 2.8bln $ Okay. (I know its more complicated than that but also.not really)" @AnotherBio on X 2025-07-16 20:15:14 UTC 1135 followers, 7754 engagements
"$BPMC might be last trading day today info from nasdaqtrader has not been accurate always (though no idea what the source for errors in the past was might not be them)" @AnotherBio on X 2025-07-16 11:03:07 UTC 1136 followers, 1370 engagements
"$BPMC lol I think thats a new one for me. You can unvalidly tender nice" @AnotherBio on X 2025-07-17 06:34:39 UTC 1136 followers, 3010 engagements
"$ILMN acquires SomaLogic from $LAB implied sales multiple probably around the 3X ballpark given deferred payment / royalties. Should reflect positively on $SEER - similar transaction would value it at 4.40$+ per share" @AnotherBio on X 2025-06-23 12:49:47 UTC 1125 followers, 1567 engagements
"Hate to be a panican and am far from deep in the woods on $REPL but I think this will weigh heavily on $XBI $BBC in the short term. Not because of the CRL per se but because of this: "The CRL also states that there are items related to the confirmatory trial study design which need to be addressed including contribution of component" This means you can basically not rely on any pre-MAHA-communication and will kill confidence from companies as well as investors. $REPL 10$ Puts changing hands for 1$ yesterday clearly show that this was not expected (especially the "oh and btw screw your" @AnotherBio on X 2025-07-22 12:26:46 UTC 1136 followers, 2564 engagements
"$PRTC Made a post already yday on strong words of CEO / Chair in annual letter but have to follow up on this after reading the transcript. This is the most shareholder-friendly language I have seen in a long time in biotech (if not ever this is biotech though so bar is low 🙃) and coming from a highly credible company - one that already actually did a buyback and tender offer. The fact that you can buy this basically unchanged from this conference call is somewhat mindblowing to me" @AnotherBio on X 2025-05-01 07:55:50 UTC 1137 followers, 4021 engagements
"There was some interest on $BPMC thought Id write down. Didnt do a "KIT inhibitor" deep dive though scientific input welcome. link in bio / comment" @AnotherBio on X 2025-07-11 13:57:46 UTC 1136 followers, 2475 engagements
"$SAGE might have a weak day. $BIIB announced its intent to tender its shares. Some folks were hoping for a last-minute-counteroffer from BIIB (they own XX% of Zuruvae) which should be completely off the table now" @AnotherBio on X 2025-07-22 12:46:15 UTC 1136 followers, 1240 engagements
"$BBIO Never talked much about this on here have sold the majority of my shares over the last couple of days. Rationale: X. At XXXX bn$ EV its a different beast than in 20s obviously X. We are all expecting strong Q2 numbers anyway X. If numbers are good KKR dumps again X. If numbers or outlook somehow disappoint (dont think so but what do I know) will be punished severely X. We are around the conversion price for over XXX bln$ of convertibles delta-hedging will put incremental pressure on the stock Just think that this combination is a tough setup into Q2 numbers but maybe Im extrapolating" @AnotherBio on X 2025-07-18 13:33:10 UTC 1137 followers, 1342 engagements